1423186-80-4
Chemical Structure
GSK2983559 active metabolite
- CAS No.: 1423186-80-4
- Formula:C21H22N4O4S2
- Molecular Weight:458.55
IUPAC Name: 2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethan-1-ol
InChIKey: UHDOJINBFLDQJM-UHFFFAOYSA-N
SMILES: CC(C)(C)S(C1=C(OCCO)C=C(N=CN=C2NC3=CC(N=CS4)=C4C=C3)C2=C1)(=O)=O
Biological Activity: GSK2983559 active metabolite is an active metabolite of GSK2983559. GSK2983559 active metabolite is a receptor interacting protein-2 (RIP2) kinase inhibitor extracted from patent WO/2014043446 A1, compound example 1.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
GSK2983559 active metabolite | 98.86% | GSK2983559 active metabolite is an active metabolite of GSK2983559. GSK2983559 active metabolite is a receptor interacting protein-2 (RIP2) kinase inhibitor extracted from patent WO/2014043446 A1, compound example 1. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords